Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation
about
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsMucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbitsAdenoviral vector immunity: its implications and circumvention strategies.The influence of innate and pre-existing immunity on adenovirus therapySelectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.Efficient amplification of chimeric adenovirus 5/40S vectors carrying the short fiber protein of Ad40 in suspension cell culturesCurrent strategies and future directions for eluding adenoviral vector immunityUnabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.Clathrin adaptor AP1B controls adenovirus infectivity of epithelial cells.Adenoviral vector-based strategies for cancer therapy.Strategies to overcome host immunity to adenovirus vectors in vaccine development.Engineered adenovirus serotypes for overcoming anti-vector immunity.Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.Progress on adenovirus-vectored universal influenza vaccines.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiberTropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.Adenoviral vectors for improved gene delivery to the inner ear.
P2860
Q26776553-8265B3E9-52E5-42FB-9A81-9266EB7ED41DQ26995655-A72F1DB6-20F8-417E-BCFC-D47F8DDBEC82Q28476839-F8EA34F8-D119-425F-A554-3C131880E314Q33565630-B3179AFD-EE2D-4C71-A834-05A6FCBC4890Q33655401-76BC7159-3B57-4674-9439-337A1197B7EBQ34343742-8AC510D0-843C-4E2F-918D-3430704AA404Q34364465-D2233F6B-DF7B-4D68-8AE4-041A73BC594CQ34585554-3157F314-D71F-41B2-9680-FAE6674A9257Q34594959-DA148014-0892-4D61-A23B-67CA827DFE99Q35139196-870ABAC4-70FE-4961-8F5D-1B31C7A3000CQ35156188-21437C14-9844-4B54-A80E-D7B1FB4D2E51Q36232223-CEFF3B26-A293-419E-A6F1-34BC14857559Q37227135-07D4A29C-026C-4C20-9415-82B04D040F90Q37256819-73D53274-1CFE-4ECC-B54F-ECB26A3E7C95Q37409025-E1D23FC2-DEED-4117-BE74-FFE8704DB661Q37503253-B833EBD4-B509-42BA-9E56-BD83CAF900B2Q37567831-AE6373A9-12BB-4F34-83C5-FED229DCC991Q37603360-5FD6212B-1554-4F25-B9C8-0295E690E5A6Q38421971-DC469223-1334-464C-88D6-1029DCBA3709Q38614156-30EC76A0-451E-4534-971F-C7B4210EF7B5Q39794990-32F035B4-2243-4DCD-A8F4-CC47AEBC6CB6Q40189728-7E434E2F-22AB-42F8-BCF7-BEC462AB4B03Q42109130-D30624E2-C221-4A75-889E-8528005CDC6D
P2860
Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Influence of fiber detargeting ...... and adaptive immune activation
@ast
Influence of fiber detargeting ...... and adaptive immune activation
@en
type
label
Influence of fiber detargeting ...... and adaptive immune activation
@ast
Influence of fiber detargeting ...... and adaptive immune activation
@en
prefLabel
Influence of fiber detargeting ...... and adaptive immune activation
@ast
Influence of fiber detargeting ...... and adaptive immune activation
@en
P2093
P2860
P1433
P1476
Influence of fiber detargeting ...... and adaptive immune activation
@en
P2093
Erik Falck-Pedersen
John W Schoggins
Marcelo Nociari
Nicola Philpott
P2860
P304
11627-11637
P356
10.1128/JVI.79.18.11627-11637.2005
P407
P577
2005-09-01T00:00:00Z